← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2013Last known activity
Apr 16, 2025
Timeline
2010s
- Jun 1, 2012
Rezolute— Founded
Drugs by trial phase (6 distinct, 7 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT07262970Lead sponsorN/A—
- NCT06881992Lead sponsorPhase 3Apr 16, 2025
- NCT06208215OfficialPhase 3Jan 11, 2024
- NCT06208215Lead sponsorPhase 3Jan 11, 2024
- NCT05712720Lead sponsorPhase 2Feb 6, 2023
- NCT04538989Lead sponsorPhase 2Dec 31, 2020
- NCT02526576Study directorPhase 2Aug 1, 2015
- NCT02526576Lead sponsorPhase 2Aug 1, 2015
- NCT01828723Overall official - principal investigatorPhase 1Apr 1, 2013
- NCT01828723Lead sponsorPhase 1Apr 1, 2013
Details
- Founded
- Indiana, PA, US Jun 1, 2012
- Last known activity
- Apr 16, 2025
Notes
Formerly known as Antria